European languages are members of the same family. The languages only differ in their grammar, their pronunciation and their most common words. pronunciation and more common words. If several languages coalesce, the grammar of the resulting.
Languages realizes why a new common language would be desirable: one could refuse to pay expensive translators. To achieve this, it would be necessary to have uniform grammar, pronunciation and more common words. If several languages coalesce, the grammar of the resulting.
Leverage agile frameworks to provide a robust synopsis for high level overviews. Iterative approaches to corporate strategy foster collaborative thinking to further the overall value proposition. Organically grow the holistic world view of disruptive innovation via workplace diversity and empowerment.
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
| NDC | 50228-0433-05 |
|---|---|
| Strength | 550 mg(EQ 500 mg base) |
| Description of pill | White, capsule shaped, film coated tablets, debossed with '433' on one side and 'SG' along with break line on other side. |
| OTC or Rx | Rx |
| Dosage Form | Tablets |
| Therapeutic category | Nonsteroidal anti-inflammatory drug (NSAID) |
| Brand Name Reference | Anaprox DS® |
| TE Code | AB |
| NDC | 50228-0433-01 |
|---|---|
| Strength | 550 mg(EQ 500 mg base) |
| Description of pill | White, capsule shaped, film coated tablets, debossed with '433' on one side and 'SG' along with break line on other side. |
| OTC or Rx | Rx |
| Dosage Form | Tablets |
| Therapeutic category | Nonsteroidal anti-inflammatory drug (NSAID) |
| Brand Name Reference | Anaprox DS® |
| TE Code | AB |
| NDC | 50228-0432-01 |
|---|---|
| Strength | 275 mg (EQ 250 mg base) |
| Description of pill | White, capsule shaped, film coated tablets, debossed with '432' on one side and 'SG' on other side. |
| OTC or Rx | Rx |
| Dosage Form | Tablets |
| Therapeutic category | Nonsteroidal anti-inflammatory drug (NSAID) |
| Brand Name Reference | Anaprox® |
| TE Code | AB |
| NDC | 50228-0176-60 |
|---|---|
| Strength | 200 mg |
| Description of pill | Pink, round, biconvex, film coated tablets, debossed with oSG, 176' onone side and plain on other side. |
| OTC or Rx | Rx |
| Dosage Form | Extended-release tablets |
| Therapeutic category | Anti-depressant |
| Brand Name Reference | Wellbutrin SR® |
| TE Code | AB |
| NDC | 50228-0175-05 |
|---|---|
| Strength | 150 mg |
| Description of pill | Purple , round, biconvex tablets, debossed with 'SG 175' on one side and plain on other side. |
| OTC or Rx | Rx |
| Dosage Form | Extended-release tablets |
| Therapeutic category | Anti-depressant |
| Brand Name Reference | Wellbutrin SR® |
| TE Code | AB |
| NDC | 50228-0175-01 |
|---|---|
| Strength | 150 mg |
| Description of pill | Purple , round, biconvex tablets, debossed with 'SG 175' on one side and plain on other side. |
| OTC or Rx | Rx |
| Dosage Form | Extended-release tablets |
| Therapeutic category | Anti-depressant |
| Brand Name Reference | Wellbutrin SR® |
| TE Code | AB |
| NDC | 50228-0175-60 |
|---|---|
| Strength | 150 mg |
| Description of pill | Purple , round, biconvex tablets, debossed with 'SG 175' on one side and plain on other side. |
| OTC or Rx | Rx |
| Dosage Form | Extended-release tablets |
| Therapeutic category | Anti-depressant |
| Brand Name Reference | Wellbutrin SR® |
| TE Code | AB |
| NDC | 50228-0174-05 |
|---|---|
| Strength | 100 mg |
| Description of pill | Blue, round, biconvex, film coated tablets, debossed with 'SG , 174' on one side and plain on other side. |
| OTC or Rx | Rx |
| Dosage Form | Extended-release tablets |
| Therapeutic category | Anti-depressant |
| Brand Name Reference | Wellbutrin SR® |
| TE Code | AB |
| NDC | 50228-0174-01 |
|---|---|
| Strength | 100 mg |
| Description of pill | Blue, round, biconvex, film coated tablets, debossed with 'SG , 174' on one side and plain on other side. |
| OTC or Rx | Rx |
| Dosage Form | Extended-release tablets |
| Therapeutic category | Anti-depressant |
| Brand Name Reference | Wellbutrin SR® |
| TE Code | AB |
| NDC | 50228-0174-60 |
|---|---|
| Strength | 100 mg |
| Description of pill | Blue, round, biconvex, film coated tablets, debossed with 'SG , 174' on one side and plain on other side. |
| OTC or Rx | Rx |
| Dosage Form | Extended-release tablets |
| Therapeutic category | Anti-depressants |
| Brand Name Reference | Wellbutrin SR® |
| TE Code | AB |